Table 1.
No. (%) by diagnostic category |
||||
---|---|---|---|---|
Lymphoid (n = 21) | Myeloid (n = 25) | Lymphoma (n = 4) | Histiocytic disorder (n = 6) | |
Gender | ||||
Male | 15 (71) | 12 (48) | 2 (50) | 3 (50) |
Female | 6 (29) | 13 (52) | 2 (50) | 3 (50) |
Age, years | ||||
Mean (median) | 9.5 (8.0) | 9.9 (10.0) | 13.8 (16) | 5.7 (2) |
Samples tested | 28 | 30 | 5 | 6 |
Primary disease | 13 (46.5) | 9 (30) | 3 (60) | 3 (50) |
Relapse/refractory | 14 (50) | 18 (60) | 1 (20) | 0 (0) |
Germlinea | 1 (3.5) | 3 (10) | 1 (20) | 3 (50) |
Platform | ||||
Tumor-normal WES with transcriptome | 23 (82) | 17 (57) | 2 (40) | 1 (17) |
Tumor-normal WES | 3 (10) | 7 (23) | 2 (40) | 0 (0) |
Constitutional WES | 1 (4) | 3 (10) | 1 (20) | 3 (50) |
Targeted cancer panel | 1 (4) | 3 (10) | 0 (0) | 2 (33) |
WES, whole exome sequencing.
aIndicates sample used for constitutional WES.